Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness analysis: from science to application.

Marc L Berger1, Steven Teutsch

  • 1Outcomes Research and Management, Merck & Co., Inc., West Point, Pennsylvania 198486, USA.

Medical Care
|August 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Methods for Research on Cannabis: A Workshop Report.

Journal of cannabis research·2025
Same author

Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union.

Bioengineering (Basel, Switzerland)·2024
Same author

When Will Real-World Data Fulfill Its Promise to Provide Timely Insights in Oncology?

JCO clinical cancer informatics·2024
Same author

The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data.

Therapeutic innovation & regulatory science·2024
Same author

HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2022
Same author

HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.

Pharmacoepidemiology and drug safety·2022
Same journal

Hepatitis C Virus Cascade of Care in Florida Emergency Departments.

Medical care·2026
Same journal

Association of Neighborhood Socioeconomic Disadvantage and Uptake of Diabetes Prevention Interventions.

Medical care·2026
Same journal

Machine Learning for Evaluating the Heterogeneous Effects of Intensive In-Hospital Rehabilitation During the Postacute Phase After Hip Fracture Surgery on Activities of Daily Living.

Medical care·2026
Same journal

Hospital-Physician Integration and Differences in the Use of Orthopedic Care Across Race and Ethnicity.

Medical care·2026
Same journal

Temporal Misalignment and Selection Bias in "Burn Pit Smoke Exposure and Sleep Apnea in US Veterans.

Medical care·2026
Same journal

The Impact of an Oncology Hospital at Home Program on Health Care Costs.

Medical care·2026
See all related articles

Improving healthcare resource allocation requires consensus on evidence standards and decision-making legitimacy. Cost-effectiveness analysis (CEA) can be a valuable tool with stakeholder engagement and transparency.

Area of Science:

  • Health Economics
  • Health Policy
  • Decision Analysis

Background:

  • Cost-effectiveness analysis (CEA) is a key tool in healthcare decision-making.
  • Methodological challenges in CEA exist but are addressable.
  • The credibility and legitimacy of healthcare resource allocation processes are critical.

Purpose of the Study:

  • To propose improvements for the credibility and utilization of CEA in healthcare.
  • To identify key areas requiring stakeholder consensus for effective healthcare policy.
  • To enhance the legitimacy of healthcare resource allocation decisions.

Main Methods:

  • The study reviews the role and challenges of CEA in healthcare decision-making.
  • It emphasizes the need for stakeholder consensus on evidence standards.

Related Experiment Videos

  • It highlights the importance of a legitimate and transparent decision-making process.

    • Main Results:

    • The primary barrier to CEA use is not its methodology but the need for consensus on evidence standards.
    • Achieving consensus on healthcare resource allocation legitimacy is paramount.
    • Broad stakeholder engagement and transparency are essential for acceptance.

    Conclusions:

    • Improving CEA's impact requires addressing evidence standards and decision-making legitimacy.
    • Stakeholder consensus on balancing competing policy goals (equity, access, individual choice) is crucial.
    • Transparent processes and broad engagement will foster acceptance of CEA in policy.